LYMPHOKINE-ACTIVATED KILLER T-CELL-ORIGINATED PROTEIN KINASE
UNII T312O1GF3M

Substance Identification & Data

This profile provides standardized clinical and technical data for Lymphokine-activated Killer T-cell-originated Protein Kinase, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T312O1GF3M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
T312O1GF3M
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LYMPHOKINE-ACTIVATED KILLER T-CELL-ORIGINATED PROTEIN KINASE
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lymphokine-activated Killer T-cell-originated Protein Kinase. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CANCER/TESTIS ANTIGEN 84
CT84
LYMPHOKINE-ACTIVATED KILLER T-CELL-ORIGINATED PROTEIN KINASE
MAPKK-LIKE PROTEIN KINASE
NORI-3
PDZ-BINDING KINASE
SPERMATOGENESIS-RELATED PROTEIN KINASE
SPK
T-LAK CELL-ORIGINATED PROTEIN KINASE
TOPK